600276.SS
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
¥50.19
+4.56%
2026-05-29
About Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Jiangsu Hengrui Pharmaceuticals Co.,Ltd, a pharmaceutical company, researches, develops, manufactures, and commercializes medicines to address unmet clinical needs in China and internationally. The company develops medicines in the areas of oncology, metabolic and cardiovascular, immunological and respiratory, neuroscience, pain management, infectious, respiratory system, hematological, ophthalmology, and autoimmune and other diseases. The company was founded in 1970 and is headquartered in Lianyungang, China.
Key Fundamentals
P/E Ratio
43.28
Forward P/E
30.81
EPS (TTM)
¥1.22
ROE
14.5%
Revenue Growth (YoY)
13.0%
Profit Margin
24.9%
Debt/Equity
0.10
Dividend Yield
0.4%
Price/Book
5.63
Beta
0.17
Market Cap
¥350.44B
Avg Volume (10D)
67.9M
Recent Breakout Signals
Recent Price Range (60 Days)
60D High
¥58.87
60D Low
¥47.62
Avg Volume
68.5M
Latest Close
¥50.19
Get breakout alerts for 600276.SS
Sign up for Breakout Scanner to receive daily notifications when 600276.SS triggers breakout signals. Build custom AI screeners and backtest strategies.
Start Free Trial7-day free trial.
Jiangsu Hengrui Pharmaceuticals Co., Ltd. (600276.SS) is listed on the Shanghai Stock Exchange (SSE). Breakout Scanner monitors 600276.SS daily for breakout patterns including long-term ceiling breakouts, momentum breakouts, and near-breakout watch setups. 600276.SS operates in the Healthcare sector within the Drug Manufacturers - Specialty & Generic industry. Data is provided for informational purposes only and does not constitute financial advice.